Nomura Holdings Inc Intra Cellular Therapies, Inc. Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $194,603 - $239,919
3,005 New
3,005 $205,000
Q1 2023

May 15, 2023
SELL
$43.8 - $56.99 $2.99 Million - $3.89 Million
-68,330 Reduced 75.72%
21,909 $1.19 Million
Q4 2022

Feb 14, 2023
SELL
$44.07 - $54.45 $3.41 Million - $4.22 Million
-77,458 Reduced 46.19%
90,239 $4.77 Million
Q3 2022

Nov 15, 2022
BUY
$42.7 - $59.99 $7.16 Million - $10.1 Million
167,697 New
167,697 $7.8 Million

Others Institutions Holding ITCI

# of Institutions
379
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email